Budesonide for swallowing problems in epidermolysis bullosa
Part of Digestive system, Ear, nose & throat, Genetic & congenital, Skin clinical trials.
This study looks at whether budesonide, a medicine that reduces inflammation, helps people with a rare skin condition called epidermolysis bullosa who have trouble swallowing. It reviews past treatment results to see if it worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of epidermolysis bullosa called dystrophic epidermolysis bullosa, either the dominant or recessive form.
- You have trouble swallowing that did not get better with usual treatments.
- You were treated with budesonide for at least one month.
- Your doctor has a record of your condition and how you responded to the treatment.
- You agree to have your medical information used for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called efgartigimod, which may help reduce harmful antibodies that attack the skin in certain blistering diseases. It is designed for people with dystrophic epidermolysis bullosa (DEB) or epidermolysis bullosa acquisita (EBA) who have antibodies against collagen VII.
This study tests whether giving budesonide (a steroid medicine) after a stretching procedure (endoscopic dilatation) for a narrowing at the site of a repaired congenital esophageal blockage can help keep the esophagus open and improve swallowing in children. It is for children under 12 who have not had prior stretching for this same narrowing and who meet other specific health criteria.
This trial tests a budesonide liquid that targets inflammation in the esophagus, stomach, and duodenum (upper digestive tract) in children with Crohn's disease. It aims to see if this treatment can reduce inflammation in those areas without strong side effects.
This trial studies whether budesonide extended-release tablets are safe and effective for improving symptoms in children ages 5–17 with active, mild to moderate ulcerative colitis. It also measures how the medicine moves through the body.
This trial tests whether a medicine called budesonide can help people with a type of chronic stomach discomfort that gets worse after meals (functional dyspepsia). If you often feel full or bloated after eating and have had a normal stomach exam, this study may be a good fit for you.
This study looks at how the immune system and the esophageal barrier function in people with eosinophilic esophagitis (EoE) compared to those without. It involves taking biopsies during an upper endoscopy to understand the disease better. The results may help improve treatments for EoE.
Hear when a new Recessive Dystrophic Epidermolysis Bullosa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.